13.45
-0.11 (-0.81%)
| Penutupan Terdahulu | 13.56 |
| Buka | 13.51 |
| Jumlah Dagangan | 344,085 |
| Purata Dagangan (3B) | 971,322 |
| Modal Pasaran | 852,175,232 |
| Harga / Pendapatan (P/E TTM) | 9.41 |
| Harga / Pendapatan (P/E Ke hadapan) | 8.80 |
| Harga / Jualan (P/S) | 2.43 |
| Harga / Buku (P/B) | 1.28 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Apr 2026 |
| Margin Keuntungan | 44.79% |
| Margin Operasi (TTM) | 20.06% |
| EPS Cair (TTM) | 2.23 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -3.00% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -23.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.90% |
| Nisbah Semasa (MRQ) | 8.73 |
| Aliran Tunai Operasi (OCF TTM) | 122.59 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 73.58 M |
| Pulangan Atas Aset (ROA TTM) | 8.62% |
| Pulangan Atas Ekuiti (ROE TTM) | 24.50% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | InMode Ltd. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 0.00 |
|
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 15.35% |
| % Dimiliki oleh Institusi | 72.07% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Doma Perpetual Capital Management Llc | 31 Dec 2025 | 2,838,431 |
| North Growth Management Ltd. | 31 Dec 2025 | 662,000 |
| Julat 52 Minggu | ||
| Median | 15.00 (11.52%) | |
| Jumlah | 1 Pegang | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Canaccord Genuity | 17 Dec 2025 | 15.00 (11.52%) | Pegang | 14.31 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 03 Feb 2026 | Pengumuman | InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference |
| 02 Feb 2026 | Pengumuman | InMode Responds to Transaction Rumors |
| 28 Jan 2026 | Pengumuman | Steel Partners Holdings L.P. Announces It Has Presented $18.00 Per Share Offer for 51% of InMode Ltd. to Board of Directors |
| 08 Jan 2026 | Pengumuman | InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |